BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scaroni C, Zilio M, Foti M, Boscaro M. Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management. Endocr Rev 2017;38:189-219. [PMID: 28368467 DOI: 10.1210/er.2016-1105] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Bleier J, Shlomai G, Fishman B, Dotan Z, Rosenzweig B, Tirosh A. The Quantitative Relationship Between Autonomous Cortisol Secretion, Dysglycemia and the Metabolic Syndrome. Endocr Pract 2020;26:974-82. [PMID: 33471702 DOI: 10.4158/EP-2020-0111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Reimondo G, Puglisi S, Pia A, Terzolo M. Autonomous hypercortisolism: definition and clinical implications. Minerva Endocrinol 2019;44:33-42. [PMID: 29963828 DOI: 10.23736/S0391-1977.18.02884-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Campana G, Loizzo S, Fortuna A, Rimondini R, Maroccia Z, Scillitani A, Falchetti A, Spampinato SM, Persani L, Chiodini I. Early post-natal life stress induces permanent adrenocorticotropin-dependent hypercortisolism in male mice. Endocrine 2021;73:186-95. [PMID: 33630246 DOI: 10.1007/s12020-021-02659-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tatsi C, Stratakis CA. Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease. Clin Perinatol 2018;45:103-18. [PMID: 29406000 DOI: 10.1016/j.clp.2017.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
5 Nishiyama M, Karashima T, Iwasaki Y, Terada Y, Fujimoto S. Unilateral adrenalectomy partially improved hyperglycemia in a patient with primary bilateral macronodular adrenal hyperplasia. Diabetol Int 2021;12:480-4. [PMID: 34567928 DOI: 10.1007/s13340-021-00503-8] [Reference Citation Analysis]
6 Chiodini I, Ramos-Rivera A, Marcus AO, Yau H. Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities. J Endocr Soc 2019;3:1097-109. [PMID: 31069279 DOI: 10.1210/js.2018-00382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Barbot M, Regazzo D, Mondin A, Zilio M, Lizzul L, Zaninotto M, Plebani M, Arnaldi G, Ceccato F, Scaroni C. Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis. Pituitary 2020;23:534-42. [PMID: 32524277 DOI: 10.1007/s11102-020-01055-x] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Jaszczyk A, Juszczak GR. Glucocorticoids, metabolism and brain activity. Neurosci Biobehav Rev 2021;126:113-45. [PMID: 33727030 DOI: 10.1016/j.neubiorev.2021.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Frara S, Allora A, Castellino L, di Filippo L, Loli P, Giustina A. COVID-19 and the pituitary. Pituitary 2021;24:465-81. [PMID: 33939057 DOI: 10.1007/s11102-021-01148-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
10 Voltan G, Boscaro M, Armanini D, Scaroni C, Ceccato F. A multidisciplinary approach to the management of adrenal incidentaloma. Expert Rev Endocrinol Metab 2021;16:201-12. [PMID: 34240680 DOI: 10.1080/17446651.2021.1948327] [Reference Citation Analysis]
11 Barbot M, Guarnotta V, Zilio M, Ceccato F, Ciresi A, Daniele A, Pizzolanti G, Campello E, Frigo AC, Giordano C, Scaroni C. Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease. Endocrine 2018;62:207-14. [DOI: 10.1007/s12020-018-1669-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ioakim KJ, Sydney GI, Paschou SA. Glucose metabolism disorders in patients with adrenal gland disorders: pathophysiology and management. Hormones (Athens) 2020;19:135-43. [PMID: 31721134 DOI: 10.1007/s42000-019-00147-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
13 Nicolas S, Rochet N, Gautier N, Chabry J, Pisani DF. The adiponectin receptor agonist AdipoRon normalizes glucose metabolism and prevents obesity but not growth retardation induced by glucocorticoids in young mice. Metabolism 2020;103:154027. [PMID: 31778708 DOI: 10.1016/j.metabol.2019.154027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Ferguson D, Hutson I, Tycksen E, Pietka TA, Bauerle K, Harris CA. Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice. Endocrinology 2020;161:bqz010. [PMID: 32036385 DOI: 10.1210/endocr/bqz010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Hillson R. Adrenal glands and diabetes. Practical Diabetes 2022;39:5-6. [DOI: 10.1002/pdi.2372] [Reference Citation Analysis]
16 Zhu K, Zhang Y, Zhang J, Zhou F, Zhang L, Wang S, Zhu Q, Liu Q, Wang X, Zhou L. Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion. Toxicol Lett 2020;320:19-27. [PMID: 31778773 DOI: 10.1016/j.toxlet.2019.11.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Aresta C, Favero V, Morelli V, Giovanelli L, Parazzoli C, Falchetti A, Pugliese F, Gennari L, Vescini F, Salcuni A, Scillitani A, Persani L, Chiodini I. Cardiovascular complications of mild autonomous cortisol secretion. Best Pract Res Clin Endocrinol Metab 2021;35:101494. [PMID: 33814301 DOI: 10.1016/j.beem.2021.101494] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lin D, Lin J, Hu X, Liu Y, Zhang J, Zhang L, Jiang J, Li X, Guo J. Preoperative prognostic nomogram for prophylactic steroid treatment of patients with subclinical Cushing's syndrome. Transl Androl Urol 2021;10:426-37. [PMID: 33532330 DOI: 10.21037/tau-20-1108] [Reference Citation Analysis]
19 Araujo-Castro M, Sampedro Núñez MA, Marazuela M. Autonomous cortisol secretion in adrenal incidentalomas. Endocrine 2019;64:1-13. [PMID: 30847651 DOI: 10.1007/s12020-019-01888-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
20 Wang D, Li HZ, Zhang YS, Wang L, Ji ZG. Is Prophylactic Steroid Treatment Mandatory for Subclinical Cushing Syndrome After Unilateral Laparoscopic Adrenalectomy? Surg Laparosc Endosc Percutan Tech 2019;29:31-5. [PMID: 30300254 DOI: 10.1097/SLE.0000000000000585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Gubbi S, Muniyappa R, Sharma ST, Grewal S, McGlotten R, Nieman LK. Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals. J Clin Endocrinol Metab 2021;106:1501-15. [PMID: 33507248 DOI: 10.1210/clinem/dgab046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 Barbot M, Ceccato F, Scaroni C. Diabetes Mellitus Secondary to Cushing's Disease. Front Endocrinol (Lausanne) 2018;9:284. [PMID: 29915558 DOI: 10.3389/fendo.2018.00284] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
23 Barbot M, Zilio M, Scaroni C. Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications. Best Practice & Research Clinical Endocrinology & Metabolism 2020;34:101380. [DOI: 10.1016/j.beem.2020.101380] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
24 Pilz S, Theiler-Schwetz V, Trummer C, Keppel MH, Grübler MR, Verheyen N, Odler B, Meinitzer A, Voelkl J, März W. Associations of Serum Cortisol with Cardiovascular Risk and Mortality in Patients Referred to Coronary Angiography. J Endocr Soc 2021;5:bvab017. [PMID: 33869979 DOI: 10.1210/jendso/bvab017] [Reference Citation Analysis]
25 Harvey I, Boudreau A, Stephens JM. Adipose tissue in health and disease. Open Biol 2020;10:200291. [PMID: 33292104 DOI: 10.1098/rsob.200291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Samson SL, Gu F, Feldt-Rasmussen U, Zhang S, Yu Y, Witek P, Kalra P, Pedroncelli AM, Pultar P, Jabbour N, Paul M, Bolanowski M. Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study. Pituitary 2021. [PMID: 34275099 DOI: 10.1007/s11102-021-01161-4] [Reference Citation Analysis]
27 Sydney GI, Michalakis K, Nikas IP, Spartalis E, Paschou SA. The Effect of Pituitary Gland Disorders on Glucose Metabolism: From Pathophysiology to Management. Horm Metab Res 2021;53:16-23. [PMID: 33045752 DOI: 10.1055/a-1258-8625] [Reference Citation Analysis]
28 Pivonello R, Elenkova A, Fleseriu M, Feelders RA, Witek P, Greenman Y, Geer EB, Perotti P, Saiegh L, Cohen F, Arnaldi G. Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study. Front Endocrinol (Lausanne) 2021;12:595894. [PMID: 33897615 DOI: 10.3389/fendo.2021.595894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Fadini GP, DiPersio JF. Diabetes mellitus as a poor mobilizer condition. Blood Rev 2018;32:184-91. [PMID: 29132746 DOI: 10.1016/j.blre.2017.11.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
30 Sanches JM, Zhao LN, Salehi A, Wollheim CB, Kaldis P. Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. FEBS J 2021. [PMID: 34847289 DOI: 10.1111/febs.16306] [Reference Citation Analysis]
31 Herndon J, Kaur RJ, Romportl M, Smith E, Koenigs A, Partlow B, Arteaga L, Bancos I. The Effect of Curative Treatment on Hyperglycemia in Patients With Cushing Syndrome. J Endocr Soc 2022;6:bvab169. [PMID: 34988348 DOI: 10.1210/jendso/bvab169] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Koracevic G, Stojkovic M, Lovic D, Pavlovic M, Kostic T, Kutlesic M, Micic S, Koracevic M, Djordjevic M. Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines? Curr Vasc Pharmacol 2020;18:12-24. [PMID: 30289080 DOI: 10.2174/1570161116666181005122339] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Chen Z, Cai Z, Zhu C, Song X, Qin Y, Zhu M, Zhang T, Cui W, Tang H, Zheng H. Injectable and Self‐Healing Hydrogel with Anti‐Bacterial and Anti‐Inflammatory Properties for Acute Bacterial Rhinosinusitis with Micro Invasive Treatment. Adv Healthcare Mater 2020;9:2001032. [DOI: 10.1002/adhm.202001032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 Kelsall A, Iqbal A, Newell-Price J. Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess. Gland Surg 2020;9:94-104. [PMID: 32206602 DOI: 10.21037/gs.2019.11.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Nazir N, Zahoor M, Ullah R, Ezzeldin E, Mostafa GAE. Curative Effect of Catechin Isolated from Elaeagnus Umbellata Thunb. Berries for Diabetes and Related Complications in Streptozotocin-Induced Diabetic Rats Model. Molecules 2020;26:E137. [PMID: 33396845 DOI: 10.3390/molecules26010137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Zhang M, Chen H, Liu MS, Zhu KY, Hao Y, Zhu DL, Li P. Serum- and glucocorticoid-inducible kinase 1 promotes insulin resistance in adipocytes via degradation of insulin receptor substrate 1. Diabetes Metab Res Rev 2021;37:e3451. [PMID: 33724645 DOI: 10.1002/dmrr.3451] [Reference Citation Analysis]
37 Hay RE, Edwards A, Klein M, Hyland L, MacDonald D, Karatsoreos I, Hill MN, Abizaid A. Ghrelin Receptor Signaling Is Not Required for Glucocorticoid-Induced Obesity in Male Mice. Endocrinology 2020;161:bqz023. [PMID: 31748785 DOI: 10.1210/endocr/bqz023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 van Wilpe R, Hulst AH, Polderman JAW, Hollmann MW, DeVries JH, Preckel B, Hermanides J. Less common types of diabetes mellitus: Incidence and glucose control in the perioperative setting. J Clin Anesth 2021;75:110460. [PMID: 34274602 DOI: 10.1016/j.jclinane.2021.110460] [Reference Citation Analysis]
39 Schernthaner-Reiter MH, Wolf P, Vila G, Luger A. The Interaction of Insulin and Pituitary Hormone Syndromes. Front Endocrinol (Lausanne) 2021;12:626427. [PMID: 33995272 DOI: 10.3389/fendo.2021.626427] [Reference Citation Analysis]
40 Ceccato F, Barbot M, Scaroni C, Boscaro M. Frequently asked questions and answers (if any) in patients with adrenal incidentaloma. J Endocrinol Invest 2021. [PMID: 34160793 DOI: 10.1007/s40618-021-01615-3] [Reference Citation Analysis]
41 Guarnotta V, Ferrigno R, Martino M, Barbot M, Isidori AM, Scaroni C, Ferrante A, Arnaldi G, Pivonello R, Giordano C. Glucocorticoid excess and COVID-19 disease. Rev Endocr Metab Disord 2020. [PMID: 33025384 DOI: 10.1007/s11154-020-09598-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
42 Lewis T, Zeisig E, Gaida J. Does glucocorticoid exposure explain the association between metabolic dysfunction and tendinopathy? Endocr Connect 2020:EC-19-0555. [PMID: 31967969 DOI: 10.1530/EC-19-0555] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Petramala L, Olmati F, Concistrè A, Russo R, Mezzadri M, Soldini M, De Vincentis G, Iannucci G, De Toma G, Letizia C. Cardiovascular and metabolic risk factors in patients with subclinical Cushing. Endocrine 2020;70:150-63. [DOI: 10.1007/s12020-020-02297-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Kuikel S, Aryal S, Basnyat RS, Rimal S, Isozaki O. Cushing Syndrome in a Pediatric Patient with Topical Steroid Overuse. Case Reports in Endocrinology 2022;2022:1-4. [DOI: 10.1155/2022/8487737] [Reference Citation Analysis]
45 Zhao Q, Zhou J, Pan Y, Ju H, Zhu L, Liu Y, Zhang Y. The difference between steroid diabetes mellitus and type 2 diabetes mellitus: a whole-body 18F-FDG PET/CT study. Acta Diabetol 2020;57:1383-93. [PMID: 32647998 DOI: 10.1007/s00592-020-01566-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Yang F, Fang B, Pang G, Ren F. Organophosphorus pesticide triazophos: A new endocrine disruptor chemical of hypothalamus-pituitary-adrenal axis. Pesticide Biochemistry and Physiology 2019;159:91-7. [DOI: 10.1016/j.pestbp.2019.05.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]